8 ms·
Looks like Mr. Cuban is demonstrating that, sometimes, a superior business plan is the shorter path to justice than waiting for the Courts and the Legislature t
by jimbokun 6y ago
Looks like Mr. Cuban is demonstrating that, sometimes, a superior business plan is the shorter path to justice than waiting for the Courts and the Legislature to catch up.
Wiping out their businesses financially might be the most effective way to fight them, in the short term.
- m463 6y agorobust competition cleans up a lot of problems. Also, as an employee having a company that has to actually compete can really eliminate a lot of BS. If you're in the 800-lb gorilla, there can be a lot of dysfunction. If you're in a company with an 800-lb gorilla, there's a good chance what you do may not matter (unless its really good).
- taurath 6y agoRobust competition doesn’t exist without strong regulation, because the natural state of competition is monopoly even with a medium barrier to entry. Almost all of our companies nowadays are high barrier to entry.
- satyrnein 6y agoIn this case, isn't the barrier to entry itself regulatory? The drug approval process stops new entrants and federal law stops consumers from buying drugs from other countries. Otherwise, I imagine there would be a pretty robust market, given that these are generics and there's no R&D involved.
- taurath 6y agoCapital costs are the barrier for a new generic drug maker, since the approval process is already done. Hense, Cuban starting a new one with his huge capital. But I’ll bet it will take lots of capital and well, they’ll find that there is no incentive to lower the price unless they want to gain market share. I suspect that pharma factories are quite expensive especially given the chemical reagent supply chain already being heavily owned or partnered with the incumbents.
- satyrnein 6y agoFrom a quick search, it seems that in the US, generic drugs still go through an approval process called ANDA, but it's simpler because there are no clinical trials. When one drug manufacturer raises prices on its generic, a lengthy approval process still inhibits other drug manufacturers from quickly introducing competing generics, even if they have the capabilities.
- chordalkeyboard 6y ago> the natural state of competition is monopoly Do you have any evidence for this assertion?
- hh3k0 6y agoIf we'd ban lobbying we wouldn't have to wait for one business to show up from somewhere else than the depths of depravity. If we'd ban lobbying we could have laws against companies that show nothing but utter disdain for life.
- h_anna_h 6y agoI think that you are being too optimistic here.
- jimbokun 6y agoSure, but what odds do you give to that happening in the near future?
- ch4s3 6y agoHow do you practically ban lobbying without removing the ability of private citizens to directly interact with the legislature? There are good reasons to allow groups of people to get together and pay someone to go hassle congress on their behalf. Regular people are busy with their own lives after all, and most of them live far away from Washington. And sometimes you want to complain to a representative from outside of you own district, because they're sponsoring legislation that would hurt you, or blocking legislation that would help you.
- Judgmentality 6y agoYou could limit the amount of money you can make via lobbying. If it was illegal to make more than $1 MM a year through lobbying, suddenly the playing field would be significantly more level. If a corporation can pay you $1 MM and a group of citizens can pay you the same, suddenly you care more about the message than the receipt. And the majority of ultra-rich lobbyists will do something else, because that's not nearly enough money to interest them. I'm not a fan of limiting salaries in general and I do not believe this is a good solution, but I believe it's likely to be better than the current situation. This is just me spitballing on a whim, having put approximately 60 seconds of thought into a solution. Hopefully people more informed will reply with better solutions or an informed explanation of what's wrong with my idea.
- mikepurvis 6y agoGiven the name and positioning of this business, I would say it's partly a PR stunt and partly an act of charity (a non-charitable approach would be to undercut by only 30-50% instead of 90%). So yeah... it's great that billionaires occasionally step up to "fix" issues created by corruption and inadequate regulation/oversight, but I think if you're going to take a position that this is somehow better than waiting for the system to fix it, it might be more instructive to look at how this works in countries with a functioning bureaucracy. For example the drug given on the homepage is Albendazole, which they're selling for $20— well guess what, that pill is $2 in the UK and has been since the patent expired in the 90s: > "In other countries, there are price control methods. The government steps in to ensure drug prices do not increase by a certain amount," Alpern says. "There are no price control mechanisms in the U.S." https://www.npr.org/sections/goatsandsoda/2017/12/11/567753423/why-a-pill-thats-4-cents-in-tanzania-costs-up-to-400-in-the-u-s https://www.npr.org/sections/goatsandsoda/2017/12/11/5677534...
- JumpCrisscross 6y ago> a non-charitable approach would be to undercut by only 30-50% instead of 90% Not if you're fighting deeply entrenched incumbents. Switching costs are huge, financially and politically. You need patients to hammer their providers to give them access to these drugs through this channel. 50% off is big, but it's something incumbents could match. 90% off leaves you with a profit margin, gets you PR points and holds the hounds at bay. Bonus: if you work out your competitors' debt loads and price at a level that they couldn't, financially, sustain.
- mikepurvis 6y agoIf the incumbent is a large scale pharmaceutical company with thousands of drugs in its portfolio, then it can most definitely afford to lose money under-cutting you when you only make a small handful. And I think that really just underscores why this approach is the Google Fiber of the US pharma market— it may be able to force prices down for a handful of select customers, and may be helpful for proving a point about true costs and the need for regulation, but its existence is most certainly not some kind of proof of the invisible hand stepping in to solve this problem on its own and that regulation is therefore unnecessary.
- at-fates-hands 6y agoWhich in turn creates another long term disaster waiting to happen.
- chadlavi 6y agoThe "sometimes" there being "when you live in a country that respects businesses more than humans" The market should never be relied on to be the one to fix injustice.
- dnautics 6y agoIf by market you mean "for profit companies", that's correct. But if "market" is taken to mean "marketplace of ideas"... In free market philosphy there is a lot of sunlight in the gap between corporate behemoths and government, ranging from individual action through mutual benefit associations all the way up to pbcs and ngos. The point is government should also not be relied upon to correct injustice. In the end justice is up to the people, and if a for-profit takes the banner of justice that's decentralization of power at work.
- vkou 6y ago> Looks like Mr. Cuban is demonstrating that, sometimes, a superior business plan is the shorter path to justice than waiting for the Courts and the Legislature to catch up. This is a very bold claim, that we do not currently have the data to evaluate. In ten or twenty years, we can revisit it, and conclude whether or not it is actually true.
- dnautics 6y agoI am super rooting for Mr. Cuban. As I alluded to in a previous post (not half a day ago), this is something I want to work on: https://news.ycombinator.com/reply?id=25925876&goto=threads%3Fid%3Ddnautics%2325925876 https://news.ycombinator.com/reply?id=25925876&goto=threads%... If I am not mistaken, the biggest challenge as I see it is that according to the FDA abandoned (generic drug) program, the Cost Plus Drug company will not be able to advertise many of its drugs to advertising monopolies that the FDA has handed out to companies (e.g. Shkreli, but also many bigger pharma companies), which according to a doctor friend of mine is a business killer. However, it's entirely likely that through sheer force of personality and name recognition, Cuban can force through a program of "check our company first", without advertising any particular drug, that gets popular among doctors. Hopefully that will drive eyes to the company without running afoul of the FDA's well intentioned but horribly gone wrong rule.
- umeshunni 6y agoIt's not really an innovative business model till California tries to pass a proposition in few years to screw over your business plan because it's not "equitable" or something.